Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Integra Lifesciences HoldingsIART -1.22%70 Shiller PE Ratio is 37.59 as of Aug. 24, 2026, which is 50% below its 10-year median of 75.50. GuruFocus rates IART with a GF Score™ of 70/100 and a GF Value™ of $20.52 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 311 Medical Devices & Instruments companies, Integra Lifesciences Holdings ranks worse than 71.7% on this metric.
The historical rank and industry rank for Integra Lifesciences Holdings's Shiller PE Ratio or its related term are showing as below:
IART'
s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.74 Med: 75.5 Max: 120.71
Current: 37.59
During the past years, Integra Lifesciences Holdings's highest Shiller PE Ratio was 120.71. The lowest was 10.74. And the median was 75.50.
IART's Shiller PE Ratio is ranked worse than 71.7% of 311
companies
in the Medical Devices & Instruments industry
Industry Median: 26.74
vs IART: 37.59
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
Integra Lifesciences Holdings's adjusted earnings per share data for the three months ended in Jun. 2026 was $0.058. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.44 for the trailing ten years ended in Jun. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
Integra Lifesciences Holdings (NAS:IART) Shiller PE Ratio Explanation
Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.
Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.
Be Aware
Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.
Integra Lifesciences Holdings Shiller PE Ratio Related Terms
Integra Lifesciences Holdings Shiller PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integra Lifesciences Holdings Shiller PE Ratio Chart
IART vs ENOV, AHCO, INSP: Shiller PE Ratio Comparison
For the Medical Devices subindustry, Integra Lifesciences Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integra Lifesciences Holdings Shiller PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Integra Lifesciences Holdings's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where Integra Lifesciences Holdings's Shiller PE Ratio falls into.
Integra Lifesciences Holdings Shiller PE Ratio Calculation
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Add all the adjusted EPS together and divide 10 will get our E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Integra Lifesciences Holdings (IART) has a Shiller PE Ratio of 37.59 as of Aug. 24, 2026. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on Integra Lifesciences Holdings and its competitors. This is 50% below median its historical median of 75.50. Over the past decade, Integra Lifesciences Holdings' Shiller PE Ratio has ranged from 10.74 to 120.71. According to the industry distribution chart, Integra Lifesciences Holdings ranks #223 out of 311 companies in the Medical Devices & Instruments industry, placing it in the top 71.7%.
Is Integra Lifesciences Holdings' Shiller PE Ratio too high?
Integra Lifesciences Holdings' current Shiller PE Ratio of 37.59 is 50% below median its 10-year median of 75.50. Over the past 10 years, this metric has ranged from a low of 10.74 to a high of 120.71. The Medical Devices & Instruments industry median Shiller PE Ratio is 26.74. Integra Lifesciences Holdings' value of 37.59 is 40.6% above this industry median. Based on the distribution chart, Integra Lifesciences Holdings ranks #223 out of 311 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Integra Lifesciences Holdings has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Integra Lifesciences Holdings' Shiller PE Ratio compare to ENOV and AHCO?
According to the Medical Devices & Instruments industry distribution chart, Integra Lifesciences Holdings ranks #223 out of 311 companies for Shiller PE Ratio. This places Integra Lifesciences Holdings in the lower half of its industry. The industry median Shiller PE Ratio is 26.74. Integra Lifesciences Holdings' value of 37.59 is 40.6% above this benchmark. Historically, Integra Lifesciences Holdings' own Shiller PE Ratio has ranged from 10.74 to 120.71 over the past decade. While the company's 10-year median is 75.50 vs. the industry median of 26.74, Integra Lifesciences Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shiller PE Ratio for a Medical Devices & Instruments company?
The median Shiller PE Ratio among Medical Devices & Instruments companies is 26.74, based on 311 companies in the industry. Companies in the top quartile (top 25%) have a Shiller PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Shiller PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integra Lifesciences Holdings's current Shiller PE Ratio of 37.59 is 40.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shiller PE Ratio mean?
A high Shiller PE Ratio can signal that a stock is expensive relative to its fundamentals. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on Integra Lifesciences Holdings and its competitors. For the Medical Devices & Instruments industry, the median Shiller PE Ratio is 26.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integra Lifesciences Holdings's current Shiller PE Ratio is 37.59, which is 50% below median its own 10-year median of 75.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integra Lifesciences Holdings stock overvalued right now?
Based on GuruFocus' analysis, Integra Lifesciences Holdings (IART) is currently considered Modestly Undervalued. The stock's GF Value™ is $20.52, compared to a current price of $16.54 — trading 19.4% below its estimated fair value. The current Shiller PE Ratio is 37.59, which is 50% below median its 10-year median of 75.50 and 40.6% above the Medical Devices & Instruments industry median of 26.74. Integra Lifesciences Holdings' overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shiller PE Ratio calculated?
Shiller PE Ratio is calculated from a company's financial statements. For Integra Lifesciences Holdings (IART), the current Shiller PE Ratio is 37.59 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integra Lifesciences Holdings (IART) Overvalued in 2026?
Based on GuruFocus' analysis, Integra Lifesciences Holdings stock appears to be undervalued.
The current stock price of $16.54 is trading 19.4% below its estimated GF Value™ of $20.52.
GuruFocus considers Integra Lifesciences Holdings to be Modestly Undervalued.
Key valuation signals for IART:
Shiller PE Ratio: 37.59 (50% below median its 10-year median of 75.50)
GF Value™: $20.52 vs. price of $16.54 (19.4% below fair value)
Industry Position: 40.6% above the Medical Devices & Instruments median (#223 of 311)
No single metric tells the full story. See the IART stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
70GF Score
Get the complete analysis for IART
Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IART has been successfully added to your 
